Breaking News, Collaborations & Alliances

NorthStar, YAP Therapeutics Partner to Develop & Manufacture Radiopharmaceuticals

NorthStar will provide non-carrier added actinium-225 (n.c.a. Ac-225) and offer CDMO services.

Author Image

By: Charlie Sternberg

Associate Editor

NorthStar Medical Radioisotopes, LLC and YAP Therapeutics, Inc. have formed a partnership to develop and manufacture radiopharmaceuticals targeting cancer and other chronic illnesses. As part of this collaboration, NorthStar will assist in the progression of YAP Therapeutics’ biologic products by providing non-carrier added actinium-225 (n.c.a. Ac-225) and offering its contract development and manufacturing (CDMO) services for radiopharmaceuticals. Moreover, NorthStar will also prepare ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters